Complicity in Harm Reduction

Area of Science:

• Public Health Ethics
• Social Policy
• Substance Use Research

Background:

• Harm reduction programs are often debated due to perceived ethical complexities.
• Concerns exist regarding complicity in immoral activities when participating in harm reduction.
• Supervised injection sites (SISs) are a key example of harm reduction interventions.

Purpose of the Study:

• To define harm reduction and clarify its scope beyond simple harm mitigation.
• To address the ethical concern of complicity for those involved in harm reduction programs.
• To analyze whether operating supervised injection sites (SISs) leads to moral complicity in harm.

Main Methods:

• Philosophical analysis using Gregory Mellema's framework on complicity.
• Examining three modes of complicity: enabling, facilitating, and condoning harm.
• Utilizing supervised injection sites (SISs) as a case study for harm reduction ethics.

Main Results:

• Operating an SIS does not inherently constitute complicity in harm.
• The fear of complicity in harm reduction is largely unwarranted.
• Conditions for potential complicity in non-consequentialist wrongdoing are outlined.

Conclusions:

• Harm reduction, exemplified by SISs, can be ethically justified without implicating operators in wrongdoing.
• A clear understanding of harm reduction and complicity is crucial for public health policy.
• Ethical frameworks support the operation of SISs as a means to reduce public health harms.